Antioxidant effects of resveratrol in cardiovascular, cerebral and metabolic diseases

Resveratrol blunts the positive effects of exercise training on cardiovascular health in aged men

Significance of wine and resveratrol in cardiovascular disease: French paradox revisited

Chronic administration of resveratrol prevents biochemical cardiovascular changes in fructose-fed rats*

Resveratrol: Preventing properties against vascular alterations and ageing

Anti-inflammatory effects of resveratrol: possible role in prevention of age-related cardiovascular disease

Resveratrol in cardiovascular disease: what is known from current research?

Resveratrol Improves Cardiovascular Function in DOCA-Salt Hypertensive Rats

Dietary polyphenols: Focus on resveratrol, a promising agent in the prevention of cardiovascular diseases and control of glucose homeostasis

Resveratrol and cardiovascular health

Resveratrol in cardiovascular health and disease

Cardiovascular effects and molecular targets of resveratrol

Resveratrol and Cardiovascular Diseases

Resveratrol: A Therapeutic Promise for Cardiovascular Diseases

Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases

Antioxidant effects of resveratrol in the cardiovascular system

Mechanisms of Cardiovascular Protection by Resveratrol

Resveratrol, a Polyphenolic Compound Found in Wine, Inhibits Tissue Factor Expression in Vascular Cells

Resveratrol in primary and secondary prevention of cardiovascular disease: a dietary and clinical perspective

One-Year Consumption of a Grape Nutraceutical Containing Resveratrol Improves the Inflammatory and Fibrinolytic Status of Patients in Primary Prevention of Cardiovascular Disease

Cardiovascular Protective Effects and Clinical Applications of Resveratrol

Antioxidant effects of resveratrol and other stilbene derivatives on oxidative stress and radical dotNO bioavailability: Potential benefits to cardiovascular diseases

Pharmacological basis and new insights of resveratrol action in the cardiovascular system

The Cardiovascular Nutrapharmacology of Resveratrol: Pharmacokinetics, Molecular Mechanisms and Therapeutic Potential

Beneficial Effects of Resveratrol Administration—Focus on Potential Biochemical Mechanisms in Cardiovascular Conditions

Subchronic oral toxicity and cardiovascular safety pharmacology studies of resveratrol, a naturally occurring polyphenol with cancer preventive activity

Resveratrol role in cardiovascular and metabolic health and potential mechanisms of action

The Effects of Resveratrol in Patients with Cardiovascular Disease and Heart Failure: A Narrative Review

Protective effects of resveratrol improve cardiovascular function in rats with diabetes

Resveratrol improves cardiovascular function and reduces oxidative organ damage in the renal, cardiovascular and cerebral tissues of two‐kidney, one‐clip hypertensive rats

Biological effects of resveratrol

High urinary levels of resveratrol metabolites are associated with a reduction in the prevalence of cardiovascular risk factors in high-risk patients

The effects of resveratrol intervention on risk markers of cardiovascular health in overweight and obese subjects: a pooled analysis of randomized controlled trials

Effect of resveratrol on metabolic and cardiovascular function in male and female adult offspring exposed to prenatal hypoxia and a high‐fat diet

Long-term low dose dietary resveratrol supplement reduces cardiovascular structural and functional deterioration in chronic heart failure in rats1

The therapeutic potential of resveratrol: a review of clinical trials

Resveratrol Prevents Cardiovascular Complications in the SHR/STZ Rat by Reductions in Oxidative Stress and Inflammation

Health Effects of Resveratrol: Results from Human Intervention Trials

Vascular Dysfunction in Aging: Potential Effects of Resveratrol, an Anti- Inflammatory Phytoestrogen

Effects of resveratrol and other wine polyphenols on vascular function: an update

Resveratrol and Cardiovascular Disease

Resveratrol Improves Vascular Function in Patients With Hypertension and Dyslipidemia by Modulating NO Metabolism